JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001563200 on April 27, 2000

J. Biol. Chem., Vol. 275, Issue 29, 22229-22237, July 21, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/29/22229    most recent
M001563200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.-J.
Right arrow Articles by Barritt, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.-J.
Right arrow Articles by Barritt, G. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of F-actin and Endoplasmic Reticulum Organization by the Trimeric G-protein Gi2 in Rat Hepatocytes

IMPLICATION FOR THE ACTIVATION OF STORE-OPERATED Ca2+ INFLOW*

Ying-Jie WangDagger, Roland B. Gregory, and Greg J. Barritt§

From the Department of Medical Biochemistry, School of Medicine, Faculty of Health Sciences, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia

Received for publication, February 25, 2000, and in revised form, April 14, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The roles of the heterotrimeric G-protein, Gi2, in regulating the actin cytoskeleton and the activation of store-operated Ca2+ channels in rat hepatocytes were investigated. Galpha i2 was principally associated with the plasma membrane and microsomes. Both F-actin and Galpha i2 were detected by Western blot analysis in a purified plasma membrane preparation, the supernatant and pellet obtained by treating the plasma membrane with Triton X-100, and after depolymerization and repolymerization of F-actin in the Triton X-100-insoluble pellet. Actin in the Triton X-100-soluble supernatant co-precipitated with Galpha i2 using either anti-Galpha i2 or anti-actin antibodies. The principally cortical location of F-actin in hepatocytes cultured for 0.5 h changed to a pericanalicular distribution over a further 3.5 h. Some Galpha i2 co-localized with F-actin at the plasma membrane. Pretreatment with pertussis toxin ADP-ribosylated 70-80% of Galpha i2 in the plasma membrane and microsomes, prevented the redistribution of F-actin, caused redistribution and fragmentation of the endoplasmic reticulum, and inhibited vasopressin-stimulated Ca2+ inflow. It is concluded that (i) a significant portion of hepatocyte Galpha i2 associates with, and regulates the arrangement of, cortical F-actin and the endoplasmic reticulum and (ii) either or both of these regulatory roles are likely to be required for normal vasopressin activation of Ca2+ inflow.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In most nonexcitable and in some excitable cells, depletion of the inositol 1,4,5-trisphosphate (InsP3)1-sensitive intracellular Ca2+ stores in the endoplasmic reticulum (ER) activates a Ca2+ influx pathway, a process known as store-operated Ca2+ influx or capacitative Ca2+ entry (1). Although it has been widely accepted that the key event initiating the opening of store-operated Ca2+ channels (SOCs) in the plasma membrane is the decrease in the concentration of Ca2+ in the lumen of the ER, neither the mechanism that couples these two events nor the structures of SOCs are well understood (2). The results of recent experiments indicate that an essential prerequisite for the activation of SOCs is the close association between regions of the ER and the plasma membrane (3). It is proposed that this association is maintained by cytoskeletal elements such as the F-actin (4). There is evidence that, in some cell types, dismantling of the F-actin cytoskeleton (5), stabilization of the F-actin cytoskeleton (6), or inhibition of myosin light chain kinase (7) blocks Ca2+ influx via SOCs while leaving Ca2+ release from the intracellular stores unaffected (but see Ref. 8).

Hepatocytes are polarized epithelial cells in which the F-actin cytoskeleton is distributed around the cortex, with a high concentration at the pericanalicular (apical) region (9). This cortical F-actin may play a role in maintaining subregions of the ER close to the plasma membrane (4). Evidence, including results obtained with a microinjected inhibitory anti-Galpha i2 antibody, indicates that the activation of SOCs in hepatocytes requires the trimeric G-protein Gi2 (10) and a brefeldin A-sensitive protein, possibly a monomeric G-protein (11). It has been reported that some Galpha i2 co-localizes with F-actin in hepatocytes in primary culture (12). Moreover, studies with other cell types have provided evidence for an association between Galpha i2 and F-actin (13-15), and have suggested a potential role for Galpha i2 in organization of the F-actin cytoskeleton (16-18). On the basis of these observations, we proposed that Gi2 may regulate arrangement of the actin cytoskeleton and the arrangement of the ER by which both the intimate plasma membrane-ER association is achieved and the communication between different parts of the ER is maintained and allows the activation of SOCs.

The aims of the present experiments were to elucidate the role of Gi2 in the activation of SOCs in hepatocytes by investigating the intracellular distribution of Galpha i2 and F-actin, the association of Galpha i2 with F-actin, and the requirement for Galpha i2-F-actin interaction in regulation of the arrangement of F-actin and in the activation of SOCs. The results indicate that a significant proportion of the cellular Galpha i2 is associated with F-actin and regulates F-actin organization (especially the cortical actin layer near the canalicular membrane) and the arrangement of the ER. To our knowledge, this is the first demonstration of the role of Galpha i2 in regulating the arrangement of F-actin in an epithelial cell type. Taken together with previous evidence that the normal function of Galpha i2 is required for the activation of SOCs in rat hepatocytes (10), these observations suggest that Galpha i2, either through regulation of cortical F-actin organization and/or arrangement of the ER, allows the normal activation of SOCs.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Affinity-purified rabbit polyclonal anti-Galpha i antibody, raised against the C-terminal decapeptide (KENLKDCGLF) of the alpha -subunit of transducin, was kindly provided by Dr. Michael Crouch (John Curtin School of Medical Research, Australian National University, Canberra, Australia). Although this antibody detects both Galpha i1 and Galpha i2, liver does not express detectable Galpha i1 (19, 20), so that the G-protein detected by this antibody in the present experiments is Galpha i2. Peptides KENLKDCGLF and QLNLKEYNLV, synthesized as described in Ref. 10, were provided by Dr. Bruce Kemp (St. Vincent's Institute of Medical Research, Victoria, Australia). Purified phosphoprotein phosphatases 1 and 2A were kind gifts from Dr. Alistair Sim (University of Newcastle, Australia). Pertussis toxin, affinity-purified rabbit polyclonal anti-actin antibody, goat anti-rabbit IgG conjugated to alkaline phosphatase, actin standard for Western blotting, protein A-Sepharose, Triton X-100, nitro blue tetrazolium, and bromochloroindolyl phosphate were from Sigma, and Texas Red-X phalloidin, 3,3'-dihexyloxacarbocyanine iodide (DiOC6(3)), fura-2, and goat anti-rabbit IgG conjugated to AlexaTM 488 were from Molecular Probes, Inc. (Eugene, OR). Recombinant Galpha i2 protein was from Calbiochem (Alexandria, Australia). All other chemicals and materials were of the highest grade commercially available.

Western Blot Analysis of Galpha i2 and Actin-- SDS-PAGE was performed on 12% polyacrylamide resolving gels with the Laemmli discontinuous buffer system (21), and the resolved proteins were electrotransferred to nitrocellulose membranes by the method of Towbin et al. (22). Membranes were blocked with M glycine containing 5% (w/v) nonfat milk powder, 5% (v/v) fetal calf serum, and 1% (w/v) ovalbumin for 1 h at room temperature and then washed three times (5 min each) at room temperature with 0.1% (v/v) Tween 20, 0.1% (w/v) nonfat milk powder, and 0.1% (w/v) ovalbumin dissolved in 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 1.4 mM KH2PO4 (pH 7.2). Membranes were incubated overnight at 4 °C with either anti-Galpha i antibody (1:200 dilution in the above wash buffer) or anti-actin antibody (1:100 dilution) or, in some cases, both antibodies together followed by incubation with secondary antibody (goat anti-rabbit IgG conjugated to alkaline phosphatase, 1:1000 dilution) for 2 h at room temperature and finally developed for 5 min in 100 mM Tris-HCl (pH 9.5), 100 mM NaCl, and 5 mM MgCl2 containing 0.33 mg/ml nitro blue tetrazolium and 0.16 mg/ml bromochloroindolyl phosphate. Quantitation of the bands was performed on a Bio-Rad model GS-700 imaging densitometer driven by the Molecular Analyst software package (Bio-Rad). SDS-PAGE in the presence of 6 M urea was conducted as described by Komatsu et al. (23).

Subcellular Fractionation and Marker Enzyme Assays-- Rat livers were homogenized in a medium containing 250 mM sucrose, 5 mM HEPES/KOH (pH 7.4), and 1 mM EGTA (homogenization medium), supplemented with 1 mM dithiothreitol, 0.2 mM phenylmethanesulfonyl fluoride, 10 µg/ml leupeptin, and 10 µg/ml pepstatin A (protease inhibitor mixture) and subcellular fractions prepared by differential centrifugation (24), with the 100,000 × g supernatant being designated the "cytosolic fraction." A purified plasma membrane fraction and a nuclei-contaminated plasma membrane fraction were prepared by Percoll gradient centrifugation (25). Protein concentrations were determined by the Bradford method (26) with bovine serum albumin as a standard. The activities of the marker enzymes 5'-nucleotidase (plasma membrane) and glucose-6-phosphatase (ER) were determined as described by Aronson and Touster (27).

Treatment of a Liver Cytosolic Fraction with Phosphoprotein Phosphatases-- The liver cytosolic fraction (100 µl) was diluted with an equivalent volume of homogenization medium supplemented with 1% (w/v) Triton X-100, 1 mM dithiothreitol, and the protease inhibitor mixture. Either 5 µl (5 units; 1 unit of the enzyme is defined as the amount that hydrolyzes 1 nmol of phosphate from the phosphorylated proteins per min at 30 °C, pH 7.0) of phosphoprotein phosphatase 1 or 5 µl (5 units) of phosphoprotein phosphatase 2A or 5 µl of vehicle (control) was added to 25 µl of the above diluted cytosolic extract. The mixture was incubated at 37 °C for 1 h, mixed with 30 µl of Laemmli sample buffer, boiled, and subjected to SDS-PAGE and Western blotting analysis.

Triton X-100 Extraction of the Plasma Membrane Fraction to Yield a Triton X-100-insoluble Pellet and a Triton X-100-soluble Supernatant and Preparation of a Repolymerized F-actin Fraction from the Plasma Membrane Triton X-100-Insoluble Pellet-- Plasma membrane pellets were resuspended in lysis buffer, which consisted of 50 mM HEPES (pH 7.4), 1% (w/v) Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM Na3VO4, 100 mM NaF, 10 mM Na4P2O7, 10% (w/v) glycerol, supplemented with the protease inhibitor mixture, and incubated on ice for 1 h. A Triton X-100-insoluble pellet and a Triton X-100-soluble supernatant were obtained by centrifugation at 14,000 × g for 10 min. F-actin present in the plasma membrane Triton X-100-insoluble pellet was subjected to two cycles of depolymerization and repolymerization as described by Ueda et al. (15), and the final fraction was called the "repolymerized F-actin fraction." All fractions were quantitatively mixed with Laemmli sample buffer for Western blot analysis.

Immunoprecipitation-- The plasma membrane Triton X-100-soluble supernatant prepared as described above was incubated on ice for 2 h with either an anti-Galpha i or an anti-actin antibody or with normal rabbit serum (as control). Samples were mixed with swollen protein A-Sepharose (5 mg, dry weight), and the incubation continued for a further 1 h. Immune complexes bound to protein A-Sepharose were collected by centrifugation (12,000 × g, 1 min). The pellets were washed three times in 0.2 M NaCl, 50 mM Tris-HCl (pH 7.4), resuspended in Laemmli sample buffer, boiled for 5 min, and centrifuged (12,000 × g, 1 min), and the supernatant was retained for SDS-PAGE and Western blotting analysis.

Treatment of Rats with Pertussis Toxin and Isolation and Culture of Hepatocytes-- Pertussis toxin (25 µg in 50 mM Tris, pH 7.5, 10 mM glycine, 0.5 M NaCl, 50% (v/v) glycerol/100 g of body weight) or vehicle was administered to Hooded Wistar rats by intraperitoneal injection (28). After 24 h, hepatocytes were isolated by collagenase perfusion (29) and grown in primary culture on type I collagen-coated coverslips (30).

The Localization of the F-actin Cytoskeleton, Galpha i2, and the Endoplasmic Reticulum-- The locations of the F-actin and ER were determined using Texas Red-X phalloidin and DiOC6(3), respectively, and confocal microscopy as described previously (31). Negative controls for ER and F-actin staining were carried out systematically by omitting DiOC6(3) and Texas Red-X phalloidin, respectively. Determination of the location of Galpha i2 by immunofluorescence was performed as described previously (10). Controls were performed by omitting either the primary antibody or the secondary antibody or both and by incubating the primary antibody with excess blocking peptide before use.

For double labeling of F-actin and Galpha i2 in the same cell, F-actin staining was first performed as described above. The cells were then washed with phosphate-buffered saline containing 0.05% (v/v) Tween 20 and 1% (w/v) bovine serum albumin (Tween solution) and incubated overnight at 4 °C with anti-Galpha i antibody (5 µg/ml in Tween solution). Thereafter, cells were washed six times with the Tween solution, incubated with secondary antibody (AlexaTM 488-conjugated goat anti-rabbit IgG, 1:100 dilution in Tween solution), and washed twice with Tween solution and four times with phosphate-buffered saline before the coverslips were mounted on slides in 50% glycerol in phosphate-buffered saline.

Confocal microscopy was performed using a Bio-Rad MRC-1000 laser-scanning confocal microscope system in combination with a Nikon Diaphot 300 inverted microscope and a × 40 NA 1.15 water immersion objective lens. The excitation and emission wavelengths were set at 568/10 and 605/35 nm, respectively, for Texas Red-X, and at 488/10 and 522/32 nm, respectively, for DiOC6(3) and AlexaTM 488. To standardize the fluorescence intensity measurements among experiments, the time of image capturing, the image intensity gain, the image enhancement, and the image black level were optimally adjusted at the outset and kept constant for each of Texas Red-X, DiOC6(3), and AlexaTM 488. In most cases, only images of the optical sections near the middle of the z axis were collected.

Quantitative examination of the captured images was performed using CoMOS (Bio-Rad) image analysis software. To quantitate F-actin distribution, for each experimental condition, 60 hepatocyte doublets were randomly selected from the images obtained from three separate cell preparations (20 doublets from each preparation), and the fluorescence (pixels) in the total doublet and in the pericanalicular area was measured. The fluorescence in the pericanalicular area was expressed as a percentage of the total doublet fluorescence. This percentage indicates the relative amount of F-actin around the bile canaliculus and hence the degree of reorganization of F-actin during primary culture (cf. Ref. 32). To avoid the subjectivity of this measurement, it was verified that the elliptical area designated as "pericanalicular area" occupied 9.95 ± 0.06% (mean ± S.E., n = 60) of the total area of control doublets and 9.92 ± 0.06% (mean ± S.E., n = 60) of the total area of pertussis toxin-treated doublets, respectively.

Electron Microscopy-- Pellets (3000 × g for 2 min) of the plasma membrane fraction (~1 mg) were fixed in 1 ml of 1% (w/v) glutaraldehyde in 25 mM HEPES buffer (pH 7.4) for 30 min on ice. After washing three times with 25 mM HEPES buffer, the samples were postfixed with 1% (w/v) OsO4 in the same HEPES buffer for 1 h on ice. Freshly isolated intact hepatocytes (pelleted by centrifugation at 80 × g for 30 s) were fixed for 2 h at room temperature in a solution containing 1% (w/v) OsO4 and 0.1 M Na2HPO4/NaH2PO4 (pH 7.4). Fixed samples were dehydrated by stepwise exposure to increasing concentrations of ethanol (50, 75, 85, 95, and 100% (v/v)) and embedded in Durcupan with propylene oxide as an intermediate transition medium. The ultrathin sections were cut on an ultramicrotome, stained with aqueous uranyl acetate and Reynold's lead citrate, and examined with a JEOL 1200 EX transmission electron microscope.

Measurement of Ca2+ Inflow-- Cytoplasmic free Ca2+ concentrations ([Ca2+]cyt) and initial rates of Ca2+ inflow (measured using a Ca2+ add-back protocol) in rat hepatocytes loaded with fura-2 by microinjection were determined using fluorescence microscopy (31).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Nature and Distribution of Galpha i2 in Rat Liver Subcellular Fractions-- When rat liver homogenates were subjected to Western blot analysis, two forms of Galpha i2, with apparent molecular masses of 41 and 43 kDa, were detected (Fig. 1A). The plasma membrane fraction contained predominantly the 41-kDa band, which co-migrated with recombinant Galpha i2 (Fig. 1B, lanes 1 and 2), while the cytosolic fraction contained predominantly the 43-kDa band (Fig. 1B, lanes 3 and 4). Treatment of cytosolic fraction with phosphoprotein phosphatase 1 converted the 43-kDa form of Galpha i2 to a form that co-migrates with recombinant Galpha i2 (Fig. 1C, lanes 1, 2, and 5). By contrast, treatment with phosphoprotein phosphatase 2A did not alter the mobility of the 43-kDa band (Fig. 1C, lanes 1, 3, and 6). These results indicate that (i) the 41-kDa form of Galpha i2 (subsequently referred to as Galpha i2) corresponds to the form of Galpha i2 (nonphosphorylated) normally detected in most cell types and (ii) the species of Galpha i2 with an apparent molecular mass of 43 kDa (subsequently referred to as phosphorylated Galpha i2) is a phosphorylated form of Galpha i2 (cf. Ref. 33).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Western blot analysis of Galpha i2 present in whole liver homogenate (A), plasma membrane and cytosolic fractions (B), and after treatment with phosphoprotein phosphatases (C). A, whole liver. Samples of rat liver homogenate were subjected to SDS-PAGE (15 µg of protein/lane) and Western blot analysis using anti-Galpha i antibody (lane 1), anti-Galpha i antibody mixed with immunizing peptide KENLKDCGLF (100 µg/ml) (lane 2), or anti-Galpha i antibody mixed with an unrelated decapeptide QLNLKEYNLV (100 µg/ml) (lane 3). The results shown are from one of three experiments that gave similar results. B, plasma membrane and cytosolic fractions. Lane 1, plasma membrane fraction (15 µg of protein); lane 2, plasma membrane fraction mixed with recombinant Galpha i2 (2 µl); lane 3, cytosolic fraction (15 µg of protein); lane 4, cytosolic fraction mixed with recombinant Galpha i2 (2 µl). Samples were subjected to SDS-PAGE and Western blotting using anti-Galpha i antibody. The results shown are from one of three experiments that gave similar results. C, the effect of treatment of the liver cytosolic fraction with phosphoprotein phosphatases on the mobility of the 43-kDa Galpha i2 band. The cytosolic extract was treated with phosphoprotein phosphatase 1 or 2A as described under "Experimental Procedures." Samples were subjected to SDS-PAGE and Western blot analysis using anti-Galpha i antibody as the probe. Lane 1, cytosolic extract; lane 2, cytosolic extract treated with phosphoprotein phosphatase 1; lane 3, cytosolic extract treated with phosphoprotein phosphatase 2A; lane 4, cytosolic extract plus recombinant Galpha i2; lane 5, cytosolic extract treated with phosphoprotein phosphatase 1 plus recombinant Galpha i2; lane 6, cytosolic extract treated with phosphoprotein phosphatase 2A plus recombinant Galpha i2. The results shown are from one of two experiments that gave similar results.

Galpha i2 was found in the plasma membrane, the nuclear-plasma membrane, and the heavy and light microsomal fractions of the liver (Fig. 2A) but was barely detectable in the cytosolic fraction. The amount of Galpha i2 associated with the microsomes was estimated to be 40% of total cellular Galpha i2. Galpha i2 (41-kDa) was the predominant form of Galpha i2 found in the plasma membrane and the nuclear plasma membrane fractions. Phosphorylated Galpha i2 was principally found in the cytosolic fraction, but some was also associated with the heavy and light microsomes (Fig. 2A). In order to determine how tightly Galpha i2 is associated with the microsomal membranes, the microsomes were treated with KCl, which has been shown to cause the dissociation of loosely bound proteins from liver microsomal membranes (34). Phosphorylated Galpha i2, but not the non-phosphorylated form, could be removed from microsomes by treatment with KCl (Fig. 2B). These results indicate that Galpha i2 is tightly associated with microsomal vesicles, whereas phosphorylated Galpha i2 is only loosely associated.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot analysis of the 41- and 43-kDa forms of Galpha i2 present in rat liver subcellular fractions (A) and before and after washing microsomal fractions with KCl (B). A, the distribution of 41- and 43-kDa Galpha i2 in subcellular fractions prepared from rat liver assessed by Western blot analysis using an anti-Galpha i antibody. The protein amount of each fraction applied to the gel was 15 µg. The results shown are from one of six experiments that gave similar results. B, the effect of washing the microsomal fractions with KCl on the amount of Galpha i2 associated with the microsomes. The heavy and light microsomal pellets were suspended in ice-cold homogenization medium supplemented with 0.15 M KCl (final concentration), incubated on ice for 5 min, and centrifuged (30 min at 35,000 × g for KCl-treated heavy microsomes, and 60 min at 100,000 × g for KCl-treated light microsomes). The resulting pellets were resuspended in wash medium, quantitatively dissolved in Laemmli sample buffer, and subjected to SDS-PAGE (15 µg of protein/lane) and Western blot analysis using anti-Galpha i antibody as a probe. The results shown are from one of two experiments that gave similar results.

The distribution of the phosphorylated and nonphosphorylated forms of Galpha i2 within hepatocytes was further analyzed by determining the degrees of enrichment of the liver subcellular fractions in the two forms of Galpha i2, 5'-nucleotidase (a plasma membrane marker enzyme) and glucose 6-phosphatase (an ER marker enzyme) (Fig. 3). The degree of enrichment of the purified plasma membrane fraction with Galpha i2 is similar to that for 5'-nucleotidase, indicating that, as shown previously (12), considerable Galpha i2 is located at the plasma membrane of hepatocytes. A small amount of glucose-6-phosphatase activity was found to be associated with the purified plasma membrane fraction. This may reflect either contamination of the plasma membrane fraction with microsomes derived from the ER or the attachment of small regions of the ER to the plasma membrane (cf. Ref. 24).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3.   The relative distribution of 41-kDa Galpha i2, 43-kDa Galpha i2, and the plasma membrane (5'-nucleotidase) and endoplasmic reticulum (glucose-6-phosphatase) markers in subcellular fractions of rat liver. The homogenization of rat liver; preparation of subcellular fractions; and determination of protein concentration, relative amounts of 41-kDa Galpha i2 and 43-kDa Galpha i2 (by Western blot analysis and densitometry), and marker enzyme activity were conducted as described under "Experimental Procedures." The degree of enrichment of a given fraction by Galpha i2 or marker enzyme was determined by dividing the amount of Galpha i2 (densitometry units) or marker enzyme (enzyme units) per mg of protein in the given subcellular fraction by the amount of Galpha i2 or marker enzyme per mg of protein in the total homogenate. The results are the means ± S.E. of three separate experiments involving separate rat liver homogenates.

The degree of enrichment of the heavy and light microsomal fractions with Galpha i2 is similar to that for glucose-6-phosphatase (Fig. 3). Consideration of the degrees of enrichment of these two fractions with 5'-nucleotidase, together with the observation that the purified plasma membrane fraction is equally enriched in 5'-nucleotidase and Galpha i2, indicates that the presence of Galpha i2 in the microsomal fractions is unlikely to be due to the contamination of these fractions by plasma membrane vesicles. The total amounts of phosphorylated Galpha i2 and Galpha i2 in the cytosolic fraction were estimated to be 84 ± 5 and 13 ± 3% (means ± S.E., n = 3 rat livers), respectively, of the total amount present in the homogenate.

Evidence for the Association of Galpha i2 and Actin in a Purified Rat Liver Plasma Membrane Fraction-- It has previously been shown that a purified liver plasma membrane fraction (prepared in a manner similar to that described above) contains F-actin, which is attached to the plasma membrane (35). Experiments were undertaken to determine whether Galpha i2 is associated with this plasma membrane-associated actin. First, the quality of the plasma membrane fraction was further assessed by electron microscopy (Fig. 4). This showed numerous extended sheets of membrane (large arrow), the presence of small vesicles adherent to some sheets (small arrows), and numerous other vesicles of varying size. The preparation was largely free of mitochondria and nuclei.


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 4.   Electron micrograph of a purified liver plasma membrane fraction. The preparation of a plasma membrane fraction from rat liver, processing of the fraction for electron microscopy, and transmission electron microscopy were performed as described under "Experimental Procedures." Scale bar, 500 nm. The image shown is representative of 10 electron micrographs from two different membrane preparations.

The plasma membrane fraction was treated with 1% (w/v) Triton X-100 to solubilize membrane lipids and integral proteins and thereby to obtain, by centrifugation, a plasma membrane Triton X-100-insoluble pellet enriched in F-actin and other cytoskeletal components (15). Galpha i2 and actin were detected by Western blotting in both the Triton X-100-insoluble pellet (predominantly F-actin) and the Triton X-100-soluble supernatant (predominantly G-actin) (Fig. 5). It was estimated by densitometric analysis that approximately 27 ± 3% (mean ± S.E., n = 4) of the total plasma membrane Galpha i2 and approximately 45 ± 1% (mean ± S.E., n = 3) of the total plasma membrane actin were recovered in the plasma membrane Triton X-100-insoluble pellet.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Western blot analysis of 41-kDa Galpha i2 and actin present in Triton X-100 extracts and a repolymerized actin fraction obtained from a purified liver plasma membrane preparation. Samples (15 µg of protein) of a purified plasma membrane preparation (lane 1), a plasma membrane Triton X-100-insoluble pellet (lane 2), a plasma membrane Triton X-100-soluble supernatant (lane 3), and a repolymerized F-actin fraction (lane 4) were subjected to SDS-PAGE and Western blot analysis using an anti-Galpha i antibody and an anti-actin antibody. The preparation of a purified plasma membrane fraction, treatment of the plasma membrane fraction with Triton X-100 to obtain an insoluble pellet and a soluble supernatant, and depolymerization and repolymerization of F-actin were conducted as described under "Experimental Procedures." The results shown are from one of three experiments each of which gave similar results.

To further test that Galpha i2 associates specifically with F-actin among the various cytoskeletal components of the plasma membrane, a repolymerized F-actin fraction was prepared from the plasma membrane Triton X-100-insoluble pellet by a two-step depolymerization-polymerization procedure (15). Analysis by SDS-PAGE and Western blotting with anti-Galpha i and anti-actin antibodies demonstrated the presence of Galpha i2 in the repolymerized F-actin fraction (Fig. 5, lane 4). Approximately 44 ± 0% of the Galpha i2 and 47 ± 2% of the actin in the plasma membrane Triton X-100-insoluble pellet were recovered in the final repolymerized F-actin fraction. This corresponds to 12 ± 0 and 21 ± 1% (means ± S.E., n = 3) of the total plasma membrane Galpha i2 and actin, respectively.

The idea that Galpha i2 and actin associate near the plasma membrane was also investigated using a co-immunoprecipitation approach. When an anti-Galpha i antibody was used to precipitate Galpha i2 from the Triton X-100-soluble supernatant of the purified plasma membrane fraction, the precipitate was found to contain actin, identified using an anti-actin antibody and Western blot analysis (Fig. 6A). When an anti-actin antibody was used to precipitate actin from the Triton X-100-soluble supernatant of the purified plasma membrane fraction, the precipitate was found to contain Galpha i2, identified using an anti-Galpha i antibody and Western blot analysis (Fig. 6B). When a similar co-immunoprecipitation experiment was performed with a liver cytosolic fraction (which is enriched in phosphorylated Galpha i2), no co-immunoprecipitation of phosphorylated Galpha i2 and actin was observed (data not shown).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   Western blot analysis of anti-Galpha i and anti-actin immunoprecipitates from a Triton X-100-soluble supernatant prepared from a purified liver plasma membrane fraction. A plasma membrane fraction was treated with Triton X-100 and centrifuged to obtain a Triton X-100-soluble supernatant. A, co-immunoprecipitation of actin by an anti-Galpha i antibody. The Triton X-100-soluble supernatant was treated with anti-Galpha i antibody (lane 1) or normal rabbit serum as a control (lane 2), as described under "Experimental Procedures." Immunoprecipitates were resolved by SDS-PAGE, Western blotted, and probed first with an anti-Galpha i antibody and subsequently an anti-actin antibody. B, co-immunoprecipitation of 41-kDa Galpha i2 by an anti-actin antibody. The Triton X-100-soluble supernatant was treated with anti-actin antibody (lane 1) or normal rabbit serum as a control (lane 2) as described under "Experimental Procedures." Immunoprecipitates were resolved by SDS-PAGE, Western blotted, and probed with first anti-Galpha i antibody and subsequently with an anti-actin antibody. The upper band labeled IgG HC is immunoglobulin heavy chain. The results shown are those from one of two experiments, each of which gave similar results.

Distribution of F-actin and Galpha i2 in Hepatocytes in Primary Culture-- The intracellular distribution of Galpha i2 and F-actin and the interaction between these proteins was further investigated using hepatocytes attached to collagen-coated coverslips, and Texas Red-X phalloidin and immunofluorescence to detect F-actin and Galpha i2, respectively. In freshly isolated rat hepatocytes allowed to attach to coverslips for 0.5 h, F-actin was observed around the cortex, in both single hepatocytes and in hepatocyte doublets (Fig. 7A). When cultured for a further 3.5 h, the amount of F-actin in single cells and in doublets decreased in most regions of the cortex. In single cells, areas of high F-actin remained in some small regions of the cortex. In doublets, a pronounced concentration of F-actin at the canalicular membranes was observed (Fig. 7C). This most likely corresponds to the re-establishment of F-actin polarity and cell polarity, as described previously (32, 36). Hepatocytes cultured for 4 h appeared to be more flattened and to have a larger diameter compared with cells cultured for 0.5 h (Fig. 7, compare C with A).


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 7.   The distribution of F-actin and Galpha i2 monitored using fluorescence microscopy, in hepatocytes derived from control and pertussis toxin-treated rats. Hepatocytes derived from vehicle-treated rats (Control) and rats treated with pertussis toxin (PTX) were cultured for 0.5 or 4 h, and the locations of F-actin (using Texas Red-X phalloidin) or Galpha i2 (using immunofluorescence) were determined as described under "Experimental Procedures." Panels I and J are images obtained when the anti-Galpha i antibody was omitted from the procedure used to detect Galpha i2. Images were obtained by confocal microscopy. The scale bars correspond to 20 µm. The images shown are representative of more than 300 cells examined from three separate control and pertussis toxin-treated cell preparations.

Substantial amounts of Galpha i2 (presumably both phosphorylated and nonphosphorylated forms) were found in the cytoplasmic space as well as at the plasma membrane of most hepatocytes examined, as shown previously (10, 12) (Fig. 7, E and G). In order to investigate the possible co-localization of Galpha i2 and F-actin, hepatocytes were double stained with Texas Red-X phalloidin and anti-Galpha i antibody (Fig. 8, A-C). The results indicate that there are regions of the cortex where the fluorescence signals representing Galpha i2 and F-actin overlap (indicated by the orange-yellow regions in Fig. 8C).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 8.   The localization of F-actin and Galpha i2 in hepatocytes. Freshly isolated hepatocytes from untreated rats were cultured for 0.5 h, fixed, stained first for F-actin with Texas Red-X phalloidin (A), incubated with primary and secondary antibodies for the detection of Galpha i2 (B), and then examined by confocal microscopy, as described under "Experimental Procedures." C, images in A and B are superimposed, revealing regions of double labeling, indicated by orange-yellow color. Scale bars, 20 µm. The images shown are representative of more than 100 cells examined from two separate cell preparations.

Effects of the Ablation of Galpha i2 Function by Pretreatment with Pertussis Toxin on the Intracellular Distribution of F-actin, Galpha i2, and the Endoplasmic Reticulum and the Activation of Ca2+ Inflow-- In order to further elucidate the role of Galpha i2 in regulation of the arrangement of the actin cytoskeleton and to study the roles of Galpha i2 and F-actin in the activation of SOCs, the treatment of rats with pertussis toxin was used to ablate Galpha i2 function. The effectiveness of pertussis toxin treatment was assessed by determining the degree of ADP-ribosylation of Galpha i2, using SDS-PAGE in the presence of 6 M urea to identify ADP-ribosylated Galpha i2 (23). Pertussis toxin treatment caused ADP-ribosylation of Galpha i2, as shown by the appearance of a new band in the urea/SDS-PAGE gel with a slower mobility than that of Galpha i2 (Fig. 9). Treatment with pertussis toxin did not result in any change in the mobility of the phosphorylated (43-kDa) Galpha i2 band (results not shown). The slower band (ADP-ribosylated Galpha i2) was observed in the plasma membrane fraction (Fig. 9A, lower panel, lane 2), the plasma membrane Triton X-100-insoluble pellet (lane 4), the plasma membrane Triton X-100-soluble supernatant (lane 6), and the heavy and light microsomal fractions (Fig. 9B). Quantitation of the bands using densitometry showed that pertussis toxin treatment resulted in ADP-ribosylation of 60, 80, and 50% of Galpha i2 in the total plasma membrane fraction, the plasma membrane Triton X-100-insoluble pellet, and the plasma membrane Triton X-100-soluble supernatant, respectively, and approximately 70% of Galpha i2 associated with the heavy plus the light microsomes.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 9.   Effects of pertussis toxin pretreatment on the degree of ADP-ribosylation of plasma membrane (A) and microsomal (B) Galpha i2, assessed by SDS-PAGE in the presence of urea. A purified plasma membrane fraction, a plasma membrane Triton X-100-insoluble pellet, a plasma membrane Triton X-100-soluble supernatant, and heavy and light microsomal fractions were prepared from the livers of control and pertussis toxin-treated rats as described under "Experimental Procedures." Samples (15 µg of protein for plasma membrane fractions and 20 µg of protein for microsomal fractions) were subjected to either SDS-PAGE (A, upper panel) or SDS-PAGE in the presence of 6 M urea (A, lower panel, and B) and Western blotted, and actin and Galpha i2 were detected using either an anti-actin antibody or an anti-Galpha i antibody. The results shown are those obtained from three separate experiments that each gave similar results.

Pertussis toxin pretreatment caused no detectable changes in the total amount of actin in the plasma membrane fraction (Fig. 9A, upper panel, compare lane 2 with lane 1). Further, since the Triton X-100-insoluble pellet contains predominantly F-actin and the Triton X-100-soluble supernatant contains mainly G-actin (6, 15), the results also indicated that pertussis toxin treatment did not change the relative distribution of the two forms of actin in the plasma membrane fraction (Fig. 9A, upper panel, compare lane 4 with lane 3 for F-actin; compare lane 6 with lane 5 for G-actin).

Cells from rats treated with pertussis toxin (pertussis toxin-treated cells) that had been cultured for 0.5 h exhibited no substantial differences in the intracellular distribution of F-actin compared with cells from vehicle-treated rats (control cells) cultured for this time (Fig. 7, compare B and A). However, the treatment with pertussis toxin prevented the redistribution of F-actin from the cortex to the bile canaliculus and other parts of the cell observed in control cells cultured for 4 h (Fig. 7, compare D and C). To quantitatively compare the differences in the distribution of F-actin in 4-h cultured doublets from control and pertussis toxin-treated rats, the pericanalicular fluorescence due to the F-actin-Texas Red-X phalloidin complex was expressed as a percentage of the total doublet fluorescence. This value was 18.87 ± 0.70% (mean ± S.E., n = 60) in control doublets compared with 11.27 ± 0.26% (mean ± S.E., n = 60) in pertussis toxin-treated doublets (p < 0.001, heteroscedastic t test). Pertussis toxin treatment also inhibited the spreading of cells observed at 4 h (Fig. 7, compare D and C). Thus, the total doublet area was 1153 ± 49 µm2 (mean ± S.E., n = 60) in control doublets compared with 936 ± 25 µm2 (mean ± S.E., n = 60) in pertussis toxin-treated doublets (p < 0.001, heteroscedastic t test).

Pertussis toxin-treated hepatocytes cultured for both 0.5 and 4 h exhibited noticeable differences in the distribution of Galpha i2 (Fig. 7, compare F and E; compare H and G). In contrast to control cells, where considerable Galpha i2 was present in the cytoplasmic space as well as at the plasma membrane, in pertussis toxin-treated cells, Galpha i2 was principally located at the plasma membrane and in the cortical region (Fig. 7, compare F and H with E and G).

Pertussis toxin-treated hepatocytes exhibited more intense staining of the ER, monitored using DiOC6(3), than that observed in control cells (Figs. 10, compare B and D with A and C). Moreover, the DiOC6(3) signal was more evenly distributed in pertussis toxin-treated cells. These differences were observed in cells cultured for both 0.5 and 4 h. Examination of the cells by electron microscopy revealed that pertussis toxin-treated hepatocytes had largely lost the regular parallel arrangement of sheets of rough ER that were observed in control hepatocytes (Fig. 11, compare B and A). These differences can be seen more clearly at higher magnification (Fig. 11, compare D and C). Moreover, in pertussis toxin-treated cells the smooth ER appeared less dense than that in control hepatocytes (Fig. 11, compare B and A).


View larger version (93K):
[in this window]
[in a new window]
 
Fig. 10.   Fluorescence micrographs of the nature and location of the endoplasmic reticulum, determined using DiOC6(3), in hepatocytes from control rats and rats treated with pertussis toxin. Hepatocytes were isolated from pertussis toxin-treated and control rats, grown on collagen-coated coverslips for either 0.5 or 4 h, fixed, stained with DiOC6(3), and examined by confocal microscopy as described under "Experimental Procedures." Scale bar, 20 µm. The images shown are representative of more than 60 cells examined from three separate cell preparations.


View larger version (156K):
[in this window]
[in a new window]
 
Fig. 11.   Electron micrographs of hepatocytes from control rats and rats treated with pertussis toxin. Hepatocytes were isolated from pertussis toxin-treated and control rats, fixed, and processed and examined by electron microscopy as described under "Experimental Procedures." Scale bars, 5 µm (A and B) and 500 nm (C and D). The images of control cells (Control) are representative of 33 out of 35 individual control hepatocytes examined from two separate cell preparations. The images of pertussis toxin-treated cells (PTX) are representative of 37 out of 44 individual pertussis toxin-treated hepatocytes examined from two separate cell preparations.

As shown previously, treatment with pertussis toxin inhibited vasopressin-stimulated Ca2+ inflow (Fig. 12). There was no detectable effect of pertussis toxin treatment on vasopressin-induced release of Ca2+ from intracellular stores (results not shown).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 12.   The effect of pretreatment with pertussis toxin on vasopressin-stimulated Ca2+ inflow. The isolation of hepatocytes from rats treated with pertussis toxin (B) or vehicle (A) and the measurement of Ca2+ inflow in single hepatocytes were performed as described under "Experimental Procedures." The additions of vasopressin (40 nM) and Ca2+ (1.5 mM) were made as indicated by the horizontal bars. Each trace is representative of those obtained for 5-13 individual cells from two separate hepatocyte preparations.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Role of Gi2 in Regulating the Organization of F-actin and the Endoplasmic Reticulum-- In keeping with the observations of others (37), a 43-kDa phosphorylated form of Galpha i2 as well as the nonphosphorylated 41-kDa form were detected in hepatocytes. The present study has focused on Galpha i2 (the 41-kDa form), which is bound to the plasma membrane and ER (microsomes), rather than on the phosphorylated 43-kDa Galpha i2, for the following reasons: (i) the phosphorylated Galpha i2 is hardly detectable in the plasma membrane fraction and is only loosely associated with the microsomes, (ii) there was no evidence from co-immunoprecipitation studies of an association between actin and phosphorylated Galpha i2, and (iii) there was no evidence that the phosphorylated Galpha i2 was ADP-ribosylated by pertussis toxin treatment.

The following observations indicate that Galpha i2 (the 41-kDa form) associates with actin at the periphery of the hepatocyte: (i) the detection of both Galpha i2 and F-actin in a Triton X-100-insoluble pellet prepared from a highly purified liver plasma membrane fraction; (ii) the detection of Galpha i2 in repolymerized actin obtained after F-actin in the plasma membrane Triton X-100-insoluble fraction was de-polymerized and re-polymerized; (iii) co-precipitation of Galpha i2 and actin from the plasma membrane Triton X-100-soluble fraction using either an anti-Galpha i antibody or an anti-actin antibody; and (iv) the observed co-localization of some Galpha i2 and F-actin at the cell periphery.

The results of experiments that employed pertussis toxin to ablate the action of Galpha i2 indicate that this trimeric G-protein is involved in regulating the organization of cortical F-actin in hepatocytes. Pertussis toxin specifically ADP-ribosylates and inactivates the alpha  subunit of Gi1, Gi2, Gi3, Go, and transducin (38). Since neither transducin, Go, nor Galpha i1 is expressed at detectable levels in hepatocytes (19, 20), Galpha i2 and Galpha i3 are the only two known targets for pertussis toxin in these cells. Moreover, there is evidence that the time course for ADP-ribosylation of Galpha i3 by pertussis toxin treatment in vivo (72 h) is longer than that for Galpha i2 (24-48 h) (23). Therefore, the in vivo pertussis toxin treatment employed in this study (24 h) is likely to result chiefly in inactivation of Galpha i2. Moreover, urea/SDS-PAGE and Western blotting confirmed that the majority of the Galpha i2 on the plasma membrane, in particular the Galpha i2 associated with F-actin, was ADP-ribosylated and hence inactivated. It is clear from our results that this pertussis toxin treatment inhibited the redistribution of F-actin from the cortex to the bile canaliculus in hepatocyte doublets and the redistribution of F-actin to specific regions of the plasma membrane in single hepatocytes. Normally, cell polarity, which is lost during isolation of hepatocytes, can be restored within 3-4 h in monolayer culture (36). This re-establishment of cell polarity has been found to be closely associated with the redistribution of F-actin from the entire cortex to the canalicular pole (i.e. the polarization of F-actin) (32). The present results indicate that Gi2 may be part of the machinery that governs the maintenance of a polarized distribution of F-actin in hepatocytes. The observation that pertussis toxin pretreatment prevented the spreading of hepatocytes in primary culture provides further evidence that Gi2 regulates F-actin organization, since it has been shown that hepatocyte spreading in culture requires F-actin organization (39).

Studies with several other types of cells have also shown that Gi2 interacts with F-actin (13-15) and is likely to play a role in regulating the organization of F-actin (16-18). For example, the degree of actin polymerization in differentiating U937 cells was found to correlate well with an increase in the amount of Galpha i2 at the plasma membrane (16). In human airway smooth muscle cells, it has been shown that Galpha i2 is required for carbachol-induced stress fiber formation (18). In experiments employing pertussis toxin, evidence has also been obtained that the dysfunction of Galpha i causes a 40-50% decrease in the cortical F-actin content in chromaffin cells (40) and diminishes fMet-Leu-Phe-induced actin polymerization in neutrophils (41). Furthermore, evidence for a link between the activity of Galpha i, the basal concentration of intracellular cyclic AMP, and the assembly of stress fibers in primary human granulosa-lutein cells has recently been reported (42). These observations, together with our present results with hepatocytes, suggest that trimeric G-proteins such as Gi2 are involved in regulating the organization of the actin cytoskeleton in a variety of cell types.

Pertussis toxin treatment also caused fragmentation and redistribution of the ER, detected using DiOC6(3) and fluorescence microscopy and by electron microscopy. Furthermore, 40% of the total cellular Galpha i2 was found to be associated with microsomes, and approximately 70% of microsome-associated Galpha i2 was ADP-ribosylated by pertussis toxin treatment. These results indicate that Gi2 is likely to be directly or indirectly involved in regulating the structure and intracellular distribution of the ER in hepatocytes. Moreover, considering the evidence of Hajnóczky et al. (43) that the luminal communication between intracellular Ca2+ stores is cooperatively modulated by GTP and the cytoskeleton, an intriguing possibility is that Gi2 is involved in maintaining the luminal continuity of the ER in hepatocytes, either via the actin cytoskeleton or by interaction with other proteins.

Pertussis toxin treatment caused a noticeable redistribution of Galpha i2 immunofluorescence from the cytoplasmic space to the cell periphery. This observation may reflect the redistribution of some Galpha i2 from the cytoplasmic space to the cell periphery. However, others have shown, using Western blotting, that compared with native Galpha i2, ADP-ribosylated Galpha i2 has a higher affinity for the anti-Galpha i antibody employed in the present studies (44). Therefore, some of the substantial increase in Galpha i2 immunofluorescence at the cortex of pertussis toxin-treated hepatocytes may be due to an enhanced affinity of the anti-Galpha i antibody for ADP-ribosylated Galpha i2 (compared with native Galpha i2).

Role of Actin and Gi2 in Activation of Ca2+ Inflow-- Pertussis toxin treatment caused a substantial inhibition of vasopressin-induced Ca2+ inflow with little effect on vasopressin-induced release of Ca2+ from intracellular stores (present and previous (30) results). Previous studies have shown that pertussis toxin treatment completely inhibits thapsigargin-induced Ca2+ inflow without a substantial effect on thapsigargin-induced release of Ca2+ from the ER (45) and have shown that the effects of pertussis toxin can be mimicked by the microinjection of an anti-Galpha i2 antibody or peptide corresponding to the carboxyl region of Galpha i2, which inhibits Gi2 function (10). These results provided substantial evidence to indicate that Gi2 (rather than Gi3, which is also present in rat hepatocytes and can be ADP-ribosylated by pertussis toxin (20, 38)) is necessary for the activation of SOCs in rat hepatocytes (10). Moreover, the previous experiments also indicate that the ablation of Galpha i2 action by pertussis toxin does not substantially affect the formation of InsP3 catalyzed by phospholipase Cbeta , the interaction of InsP3 with InsP3 receptors, the ability of InsP3 receptors to release Ca2+ from most regions of the ER, or the interaction of thapsigargin with the ER (Ca2+ + Mg2+)-ATPase and the inhibition of this Ca2+ pump. (The possibility that ablation of Galpha i2 affects the release of Ca2+ from a small region of the ER near the plasma membrane that is central to the activation of SOCs but was not detected as a reduction in vasopressin-induced release of Ca2+ from intracellular stores cannot be excluded.)

The present results show that two of the functions of Gi2 in hepatocytes are to regulate F-actin assembly at the cortex and arrangement of the ER. It is possible that one or both of these functions is essential for the activation of SOCs. Thus, as suggested by others, the activation of SOCs may require maintenance of a region of the ER near the plasma membrane (e.g. "docking" of regions of the ER with the plasma membrane and/or the fusion of vesicles containing SOC proteins with the plasma membrane (6, 46)). In this respect, it is interesting to note that the effects of Galpha i2 ablation (pertussis toxin treatment) in stabilizing F-actin at the hepatocyte cortex and inhibiting SOC activation are similar to results recently reported by Patterson et al. (6). These authors showed that, in a smooth muscle cell line, the stabilization of F-actin by different procedures (treatment with jasplakinolide or calyculin A, which induced the formation of a dense ring of F-actin around the cell periphery) also inhibited SOC activation (6).

A requirement for Gi2 in the activation of SOCs has not been reported in studies of most other mammalian cells (47). This suggests that the requirement for Gi2 in SOC activation in hepatocytes (10) reflects one or more aspects of the specific structure and function of these cells, such as maintenance (via Gi2 regulation of the actin cytoskeleton or interaction of Gi2 with another ER-associated protein) of cell polarity and/or a specific distribution of the ER throughout the cell, which is critical for the activation of SOCs. This may be due to a requirement for Gi2 in the regulation of F-actin organization that is more accentuated in hepatocytes than in other cell types. Another possibility is that, in the hepatocyte, the InsP3 receptors principally involved in inducing a decrease in Ca2+ in the lumen of the ER are located some distance from the SOCs so that normal intraluminal communication through the ER is required for SOC activation (cf. Ref. 48).

    ACKNOWLEDGEMENTS

We gratefully acknowledge Dr. Michael Crouch (Australian National University) for providing anti-Galpha i antibody, Dr. Alistair Sim (University of Newcastle) for gifts of purified phosphoprotein phosphatase 1 and phosphoprotein phosphatase 2A, Dr. Peter Kolesik (University of Adelaide) for performing the confocal microscopy, and Kerry Gascoigne and Dr. Chris Lunam (Department of Anatomy and Histology, Flinders University) for assistance with electron microscopy. We thank David Doherty for the preparation of hepatocytes and Diana Tanevski for the preparation of the typescript.

    FOOTNOTES

* This work was supported by a grant from the National Health and Medical Research Council of Australia.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of an Australian Overseas Postgraduate Research Scholarship and a Flinders University Research Scholarship.

§ To whom correspondence should be addressed. Tel.: 61 8 8204 4260; Fax: 61 8 8374 0139; E-mail: Greg.Barritt@flinders.edu.au.

Published, JBC Papers in Press, April 27, 2000, DOI 10.1074/jbc.M001563200

    ABBREVIATIONS

The abbreviations used are: InsP3, inositol 1,4,5-trisphosphate; SOC, store-operated Ca2+ channel; ER, endoplasmic reticulum; DiOC6(3), 3,3'-dihexyloxacarbocyanine iodide; PAGE, polyacrylamide gel electrophoresis; F-actin, filamentous actin; G-actin, globular actin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Putney, J. W., Jr. (1997) Capacitative Calcium Entry , Landes Biomedical Publishing, Austin, TX
2. Barritt, G. J. (1999) Biochem. J. 337, 153-169
3. Putney, J. W., Jr. (1999) Cell 99, 5-8
4. Rossier, M. F., Bird, G. S. J., and Putney, J. W., Jr. (1991) Biochem. J. 274, 643-650
5. Holda, J. R., and Blatter, L. A. (1997) FEBS Lett. 403, 191-196
6. Patterson, R. L., van Rossum, D. B., and Gill, D. L. (1999) Cell 98, 487-499
7. Watanabe, H., Takahashi, R., Zhang, X.-X., Goto, Y., Hayashi, H., Ando, J., Isshiki, M., Seto, M., Hidaka, H., Niki, I., and Ohno, R. (1998) FASEB J. 12, 341-348
8. Ribeiro, C. M. P., Reece, J., and Putney, J. W., Jr. (1997) J. Biol. Chem. 272, 26555-26561
9. French, S. W., Cadrin, M., Kawahara, H., and Kachi, K. (1993) in Molecular and Cellular Biology of the Liver (LeBouton, A. V., ed) , pp. 143-180, CRC Press, Inc., Boca Raton, FL
10. Berven, L. A., Crouch, M. F., Katsis, F., Kemp, B. E., Harland, L. M., and Barritt, G. J. (1995) J. Biol. Chem. 270, 25893-25897
11. Fernando, K. C., Gregory, R. B., Katsis, F., Kemp, B. E., and Barritt, G. J. (1997) Biochem. J. 328, 463-471
12. Cadrin, M., McFarlane-Anderson, N., Harper, M.-E., Gaffield, J., and Bégin-Heick, N. (1996) J. Cell. Biochem. 62, 334-341
13.